Esperion Therapeutics | ESPR - Assets


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Esperion Therapeutics

Esperion Therapeutics reported $251.82M in Assets for its fiscal quarter ending in March of 2023.


Assets Change
Alnylam Pharmaceuticals ALNY:US USD 3.39B 154.42M
Amarin AMRN:US USD 860.19M 25.99M
Amgen AMGN:US USD 88.72B 23.6B
Biogen BIIB:US USD 24.6B 44.3M
BioMarin Pharmaceutical BMRN:US USD 6.43B 58.62M
Cytokinetics CYTK:US USD 889.82M 124.96M
Daiichi Sankyo 4568:JP JPY 2.51T 110.86B
Eli Lilly LLY:US USD 53.16B 3.67B
Esperion Therapeutics ESPR:US USD 251.82M 3.88M
Geron GERN:US USD 424.88M 234.3M
Halozyme Therapeutics HALO:US USD 1.7B 142.06M
Heron Therapeutics HRTX:US USD 220.88M 30.07M
Intercept Pharmaceuticals ICPT:US USD 504.08M 49.63M
Intra Cellular Therapies ITCI:US USD 722.16M 32.62M
Ionis Pharmaceuticals IONS:US USD 2.89B 351.34M
Minerva Neurosciences NERV:US USD 51.6M 3.49M
Moderna Inc MRNA:US USD 24.12B 1.73B
Nektar Therapeutics NKTR:US USD 561.74M 148.86M
PTC Therapeutics PTCT:US USD 1.61B 96.78M
Puma Biotechnology PBYI:US USD 196.26M 25.8M
Regeneron Pharmaceuticals REGN:US USD 30.06B 845.4M
Sarepta Therapeutics SRPT:US USD 3.06B 68.58M
Seattle Genetics SGEN:US USD 3.54B 131.24M
United Therapeutics UTHR:US USD 6.35B 301.5M
Vanda Pharmaceuticals VNDA:US USD 644.53M 10.28M